HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

G Viale Selected Research

taxane

1/2018Pertuzumab, trastuzumab, and standard anthracycline- and taxane-based chemotherapy for the neoadjuvant treatment of patients with HER2-positive localized breast cancer (BERENICE): a phase II, open-label, multicenter, multinational cardiac safety study.
11/2008Is risk of central nervous system (CNS) relapse related to adjuvant taxane treatment in node-positive breast cancer? Results of the CNS substudy in the intergroup Phase III BIG 02-98 Trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


G Viale Research Topics

Disease

74Breast Neoplasms (Breast Cancer)
04/2024 - 01/2000
54Neoplasms (Cancer)
04/2024 - 01/2000
19Neoplasm Metastasis (Metastasis)
12/2022 - 01/2001
10Triple Negative Breast Neoplasms
11/2022 - 01/2011
9Carcinoma (Carcinomatosis)
09/2009 - 01/2000
4Noninfiltrating Intraductal Carcinoma (DCIS)
01/2017 - 12/2005
3Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
04/2024 - 02/2003
3Adenocarcinoma
04/2007 - 03/2001
3Lymphatic Metastasis
03/2007 - 06/2000
2Lung Neoplasms (Lung Cancer)
04/2024 - 08/2009
2Carcinogenesis
12/2022 - 06/2000
2Pathologic Complete Response
01/2022 - 12/2016
2Residual Neoplasm
01/2017 - 02/2015
2Hemangiosarcoma (Angiosarcoma)
05/2015 - 07/2014
2Ductal Carcinoma
10/2013 - 08/2001
2Adenosquamous Carcinoma
02/2003 - 03/2001
2Squamous Cell Carcinoma (Epidermoid Carcinoma)
02/2003 - 03/2001
2Lymphoma (Lymphomas)
11/2001 - 08/2000
2Epstein-Barr Virus Infections
10/2001 - 06/2000
1Brain Stem Neoplasms (Brain Stem Tumor)
06/2021
1Heart Failure
01/2018
1Cardiotoxicity
01/2018
1Insulin Resistance
11/2013
1Necrosis
04/2013
1Atrial Fibrillation
08/2012

Drug/Important Bio-Agent (IBA)

17Estrogen ReceptorsIBA
10/2020 - 08/2000
13Hormones (Hormone)IBA
04/2024 - 08/2000
13Progesterone Receptors (Progesterone Receptor)IBA
03/2013 - 01/2000
12human ERBB2 proteinIBA
04/2024 - 04/2008
10Phenobarbital (Luminal)FDA Link
09/2020 - 10/2010
9TamoxifenFDA LinkGeneric
12/2015 - 05/2007
7Methotrexate (Mexate)FDA LinkGeneric
01/2024 - 01/2002
7Biomarkers (Surrogate Marker)IBA
12/2022 - 11/2004
6Cyclophosphamide (Cytoxan)FDA LinkGeneric
01/2024 - 01/2002
6Letrozole (Femara)FDA LinkGeneric
10/2021 - 05/2007
5Proteins (Proteins, Gene)FDA Link
05/2015 - 06/2000
5Fluorouracil (Carac)FDA LinkGeneric
10/2011 - 11/2001
4ErbB Receptors (EGF Receptor)IBA
04/2024 - 04/2015
4Trastuzumab (Herceptin)FDA Link
01/2018 - 12/2007
4Hematoxylin (Haematoxylon)IBA
02/2015 - 06/2001
4Eosine Yellowish-(YS) (Eosin)IBA
02/2015 - 06/2001
4Messenger RNA (mRNA)IBA
10/2007 - 06/2000
4Monoclonal AntibodiesIBA
03/2001 - 01/2000
3Estrogens (Estrogen)FDA Link
10/2021 - 01/2000
3AnthracyclinesIBA
01/2018 - 11/2001
3Aromatase InhibitorsIBA
10/2011 - 05/2007
3Vinorelbine (Navelbine)FDA LinkGeneric
11/2008 - 11/2001
3Indicators and Reagents (Reagents)IBA
10/2007 - 06/2000
2trastuzumab deruxtecanIBA
04/2024 - 04/2024
2Immunoconjugates (Immunoconjugate)IBA
04/2024 - 01/2023
2LigandsIBA
10/2018 - 06/2000
2taxaneIBA
01/2018 - 11/2008
2Insulin-Like Growth Factor I (IGF-1)IBA
03/2014 - 06/2000
2Docetaxel (Taxotere)FDA Link
05/2013 - 11/2008
2Goserelin (Zoladex)FDA Link
10/2011 - 02/2010
2fascinIBA
04/2007 - 02/2003
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
02/2006 - 01/2002
2Cisplatin (Platino)FDA LinkGeneric
10/2003 - 11/2001
2Keratins (Keratin)IBA
12/2001 - 06/2001
2Protein Isoforms (Isoforms)IBA
08/2001 - 01/2000
2Coloring Agents (Dyes)IBA
08/2001 - 10/2000
2AntibodiesIBA
08/2001 - 06/2000
1Ado-Trastuzumab EmtansineIBA
04/2024
1telisotuzumab vedotinIBA
04/2024
1Surface Antigens (Surface Antigen)IBA
04/2024
1sacituzumab govitecanIBA
04/2024
1patritumab deruxtecanIBA
04/2024
1Serine (L-Serine)FDA Link
12/2022
1Folic Acid (Vitamin M)FDA LinkGeneric
12/2022
1CarbonIBA
12/2022
1Cyclin-Dependent Kinases (cdk Proteins)IBA
12/2022
1AntimetabolitesIBA
12/2022
1Poly Adenosine Diphosphate RiboseIBA
12/2022
1olaparibIBA
12/2022
1Glycine (Aminoacetic Acid)FDA LinkGeneric
12/2022
1atezolizumabIBA
01/2022
1pertuzumabIBA
01/2018
1Diphosphonates (Bisphosphonates)IBA
01/2017
1Sex Hormone-Binding GlobulinIBA
03/2014
1C-Reactive ProteinIBA
03/2014
1DNA Nucleotidylexotransferase (Terminal Deoxynucleotidyl Transferase)IBA
11/2013
1Metformin (Glucophage)FDA LinkGeneric
11/2013
1ProgesteroneFDA LinkGeneric
10/2013
1Androgen Receptors (Androgen Receptor)IBA
09/2013
1Doxorubicin (Adriamycin)FDA LinkGeneric
05/2013
1Quinidine (Chinidin)FDA LinkGeneric
08/2012
1Retinoic Acid Receptor alphaIBA
05/2011
1Promyelocytic Leukemia ProteinIBA
05/2011

Therapy/Procedure

27Therapeutics
04/2024 - 12/2003
26Drug Therapy (Chemotherapy)
12/2022 - 08/2000
10Radiotherapy
12/2017 - 08/2006
8Neoadjuvant Therapy
01/2022 - 01/2007
6Adjuvant Chemotherapy
01/2024 - 11/2008
2Immunotherapy
11/2022 - 01/2017
2Segmental Mastectomy (Lumpectomy)
12/2017 - 10/2003
2Mastectomy (Mammectomy)
09/2009 - 12/2005
2Combination Drug Therapy (Combination Chemotherapy)
08/2008 - 12/2006
2Lymph Node Excision (Lymph Node Dissection)
08/2006 - 09/2001
2ViFuP protocol
10/2003 - 11/2001
1Maintenance Chemotherapy
12/2022